RWS Holdings
470p
9.0 2.0%
market vs.
industry Growth & Value
| 12m Forecast Rolling | ||||
| PE Ratio (f) | 29.4 |
|
|
|
| PEG Ratio (f) |
|
|
||
| EPS Growth (f) | % |
|
|
|
| Dividend Yield (f) | % |
|
|
|
| Valuation (ttm) | ||||
| Price to Book Value | 8.42 |
|
|
|
| Price to Tang. Book |
|
|
||
| Price to Free Cashflow |
|
|
||
| Price to Sales |
|
|
||
| EV to EBITDA |
|
|
||
market vs.
industry Quality
| Year End 30th Sep | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | TTM | 2017E | 2018E | CAGR / Avg | |
| Revenue | £m | ||||||||||
| Operating Profit | £m | ||||||||||
| Net Profit | £m | ||||||||||
| EPS Reported | p | ||||||||||
| EPS Normalised | p | ||||||||||
| EPS Growth | % | ||||||||||
| PE Ratio | x | ||||||||||
| PEG | x | ||||||||||
| Profitability | |||||||||||
| Operating Margin | % | ||||||||||
| ROA | % | ||||||||||
| ROCE | % | ||||||||||
| ROE | % | ||||||||||
| Cashflow | |||||||||||
| Op. Cashflow ps | p | ||||||||||
| Capex ps | p | ||||||||||
| Free Cashflow ps | p | ||||||||||
| Last ex-div: 29th Jun, paid: 21st Jul more... Dividends | |||||||||||
| Dividend ps | p | ||||||||||
| Dividend Growth | % | ||||||||||
| Dividend Yield | % | ||||||||||
| Dividend Cover | x | ||||||||||
| Balance Sheet | |||||||||||
| Cash etc | £m | ||||||||||
| Working Capital | £m | ||||||||||
| Net Fixed Assets | £m | ||||||||||
| Net Debt | £m | ||||||||||
| Book Value | £m | ||||||||||
| Average Shares | m | ||||||||||
| Book Value ps | p | +12.9% | |||||||||
| Leverage (ttm) | Total | -Intang | +Pension | ||
| Gross Gearing | % | ||||
| Net Gearing | % | ||||
| Cash / Assets | % |
| Liquidity (ttm) | ||
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | |
| Asset Turnover | |
| Rec's Turnover | |
| Stock Turnover | |
market vs.
industry Recent History
| Latest interim period (ended 31st Mar '17) vs. prior year | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| 3yr Compound Annual Growth Rate | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| DPS Growth | % |
|
|
|
Broker Consensus Trend
| Recommendation: | Strong Sell | Sell | Hold | Buy | Strong Buy |
|---|---|---|---|---|---|
| No. of Analysts: | 0 | 0 | 3 | 0 | 0 |
RWS Holdings plc is a holding company, which provides patent translations, intellectual property support services, technical and commercial translations and linguistic validation services, through its subsidiaries. The Company's segments include Patent translation division, Life science division, Commercial division and Information division. The Patent translation division provides patent and technical document translation and filing services with offices in the United Kingdom, the United States, Europe, Japan and China. The Life science division provides technical translations and linguistic validation to medical and pharmaceutical sector. The Life science division includes Corporate Translations Inc., and medical translation and Pharmaquest linguistic validation businesses. The Commercial division provides non patent technical translation and localization services. The Information division offers patent search, retrieval and monitoring services, and patent database service, PatBase.
Directors: Andrew Brode (CHM) 67, Richard Thompson (CEO) 53, David Shrimpton (NVC) 71, Elisabeth Lucas (NED) 59, Lara Boro (NID) ,
No. of Employees: 887 No. of Shareholders: n/a
| Last Annual | September 30th, 2016 |
| Last Interim | March 31st, 2017 |
| Incorporated | December 16, 1994 |
| Public Since | April 19, 2000 |
| Shares in Issue | 272,890,637 |
| Free Float | 138.3m (50.7%) |
| Sector | Industrials |
| Industry | Professional & Commercial Services |
| Index | FTSE Aim All Share , FTSE Aim 100 , FTSE Intl-aim UK 50 , |
| Exchange |
London Stock Exchange (AIM)
|
| Eligible for | an ISA? a SIPP? |
| Address | Europa House,Chiltern Park Chiltern Hill, GERRARDS CROSS, SL9 9FG, United Kingdom |
| Web | http://www.rws.com |
| Phone | +44 1753 480200 |
| Contact | () |
| Auditors | PricewaterhouseCoopers LLP |
Recent ↓
Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2017.
